Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2024-02-08 | 2024-04-18 | 218974 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2024-03-18 | 2024-04-11 | 222566 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-01-12 | 2023-01-19 | 180881 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-06 | 2021-01-07 | 121852 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-27 | 2020-09-17 | 123078 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124918 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-19 | 2020-07-10 | 94384 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135129 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-06-26 | 2023-07-12 | 196367 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-05 | 199106 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-06 | 199390 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-04-27 | 2023-08-18 | 190734 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2022-03-04 | 2022-04-21 | 156058 |
| ACT RALOXIFENE | 60MG | TABLET | Actual shortage | 2025-05-02 | 2025-05-02 | 256459 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195781 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |
| TEVA-DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2025-03-20 | 2025-03-20 | 253156 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2025-04-25 | 2025-04-25 | 255812 |
| TEVA-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256131 |
| TEVA-DICLOFENAC-K | 50MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253168 |
| TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81307 |
| TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85572 |
| TEVA-DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85575 |
| TEVA-DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97232 |
| TEVA-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97235 |
| TEVA-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97238 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256134 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |